These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 18790660

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
    Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M.
    Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM, Kingston J, Hungerford JL.
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Treatment of overt extraocular retinoblastoma.
    Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E.
    Med Pediatr Oncol; 2003 Mar; 40(3):158-61. PubMed ID: 12518344
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Late presentation of retinoblastoma in Malaysia.
    Menon BS, Alagaratnam J, Juraida E, Mohamed M, Ibrahim H, Naing NN.
    Pediatr Blood Cancer; 2009 Feb; 52(2):215-7. PubMed ID: 18855905
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis.
    Armenian SH, Panigrahy A, Murphree AL, Jubran RF.
    Pediatr Blood Cancer; 2008 Oct; 51(4):479-84. PubMed ID: 18478574
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL, Dunkel IJ, Antoneli CB, de Dávila MT, Arias V, Beaverson K, Fandiño AC, Chojniak M, Abramson DH.
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [Abstract] [Full Text] [Related]

  • 35. Retinoblastoma in children older than 5 years of age.
    de Aguirre Neto JC, Antoneli CB, Ribeiro KB, Castilho MS, Novaes PE, Chojniak MM, Arias V.
    Pediatr Blood Cancer; 2007 Mar; 48(3):292-5. PubMed ID: 16847922
    [Abstract] [Full Text] [Related]

  • 36. [Treatment modalities and results of comprehensive therapy for extended retinoblastoma in children].
    Belkina BM, Durnov LA, Poliakov VG, Goldobenko GV, Glekov IV, Ushakova TL.
    Vopr Onkol; 1997 Mar; 43(4):435-9. PubMed ID: 9381699
    [Abstract] [Full Text] [Related]

  • 37. Socioeconomic impact of modern multidisciplinary management of retinoblastoma.
    Wilson MW, Haik BG, Rodriguez-Galindo C.
    Pediatrics; 2006 Aug; 118(2):e331-6. PubMed ID: 16882777
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preliminary experience in treatment of papillary and macular retinoblastoma: evaluation of local control and local complications after treatment with linear accelerator-based stereotactic radiotherapy with micromultileaf collimator as second-line or salvage treatment after chemotherapy.
    Pica A, Moeckli R, Balmer A, Beck-Popovic M, Chollet-Rivier M, Do HP, Weber DC, Munier FL.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1380-6. PubMed ID: 20932660
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.